We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$82.1B
AUM Growth
+$7.21B
Cap. Flow
+$2.14B
Cap. Flow %
2.6%
Top 10 Hldgs %
34.14%
Holding
3,101
New
616
Increased
843
Reduced
896
Closed
659

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$495M
2
SPOT icon
Spotify
SPOT
+$377M
3
HUM icon
Humana
HUM
+$350M
4
GS icon
Goldman Sachs
GS
+$324M
5
MRK icon
Merck
MRK
+$307M

Sector Composition

Rank Sector Weight
1 Technology 18.11%
2 Consumer Discretionary 14.61%
3 Healthcare 12.89%
4 Industrials 6.78%
5 Financials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGNI icon
276
Magnite
MGNI
$2.65B
$50.5M 0.06%
3,644,267
+2,084,747
+134% +$28.4M
HOOD icon
277
Robinhood
HOOD
$85.2B
$50.5M 0.06%
2,154,451
+500,368
+30% +$10.5M
TD icon
278
Toronto Dominion Bank
TD
$198B
$50.2M 0.06%
794,301
-673,898
-46% -$39.8M
NUE icon
279
Nucor
NUE
$56.4B
$50.2M 0.06%
334,150
+251,351
+304% +$37.8M
ALK icon
280
Alaska Air
ALK
$5.15B
$50M 0.06%
1,106,836
+1,000,960
+945% +$38M
TEVA icon
281
Teva Pharmaceuticals
TEVA
$35.9B
$49.5M 0.06%
2,744,982
-1,427,611
-34% -$25M
INTU icon
282
PUT
Intuit
INTU
$81.1B
$49.4M 0.06%
79,500
+31,500
+66% +$20.1M
KMX icon
283
CarMax
KMX
$8.27B
$49M 0.06%
633,368
-527,233
-45% -$41.7M
BC icon
284
Brunswick
BC
$5.19B
$49M 0.06%
584,166
+567,007
+3,304% +$44M
KRE icon
285
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
$48.8M 0.06%
863,058
+661,807
+329% +$36.3M
PHM icon
286
Pultegroup
PHM
$24.5B
$48.4M 0.06%
+337,182
New +$42.9M
RVMD icon
287
Revolution Medicines
RVMD
$40.2B
$48.3M 0.06%
1,064,999
+248,944
+31% +$10.8M
CHD icon
288
Church & Dwight Co
CHD
$23.1B
$48.1M 0.06%
459,391
-641,019
-58% -$65.8M
EXP icon
289
Eagle Materials
EXP
$6.6B
$48.1M 0.06%
+167,185
New +$41.8M
NEM icon
290
Newmont
NEM
$98.2B
$47.9M 0.06%
896,547
+838,260
+1,438% +$41.6M
GD icon
291
General Dynamics
GD
$105B
$47.2M 0.06%
156,297
+126,363
+422% +$37.1M
BCC icon
292
Boise Cascade
BCC
$2.74B
$47.1M 0.06%
334,234
+143,187
+75% +$18.7M
XENE icon
293
Xenon Pharmaceuticals
XENE
$6.32B
$47.1M 0.06%
1,195,480
-189,194
-14% -$7.63M
ZIM icon
294
ZIM Integrated Shipping Services
ZIM
$3B
$46.5M 0.06%
1,812,108
-585,203
-24% -$11.4M
GMED icon
295
Globus Medical
GMED
$10.4B
$46.5M 0.06%
649,510
-308,224
-32% -$21.8M
SLV icon
296
CALL
iShares Silver Trust
SLV
$28.1B
$46.3M 0.06%
1,629,000
-1,144,300
-41% -$30.7M
LEN icon
297
Lennar Class A
LEN
$20.4B
$46.1M 0.06%
254,194
-1,827,963
-88% -$306M
NOW icon
298
ServiceNow
NOW
$102B
$45.9M 0.06%
256,585
+33,085
+15% +$5.44M
RJF icon
299
Raymond James Financial
RJF
$32.5B
$45.8M 0.06%
373,612
-608,044
-62% -$71M
HRI icon
300
Herc Holdings
HRI
$5.43B
$45.7M 0.06%
286,504
+205,748
+255% +$29.2M

Similar funds

Marshall Wace's Q3 2024 Portfolio in Review

As of Q3 2024, Marshall Wace held 3,101 positions worth $82.1B, up 9.6% from $74.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Marshall Wace's Q3 2024 filing shows 616 new, 843 increased, 896 reduced and 659 closed positions. Its largest new stake was Texas Instruments: 1,008,812 shares worth $208M. The largest sale was Costco, an estimated $495M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q3 2024 buy was Texas Instruments: 1,008,812 shares worth $208M.
  • Marshall Wace added most to Tesla in Q3 2024, an estimated $700M increase.
  • Marshall Wace's biggest Q3 2024 reduction was Costco, cutting an estimated $495M.
  • Marshall Wace fully exited Shopify in Q3 2024, selling an estimated $209M.
  • Marshall Wace's ten largest holdings make up 34% of its $82.1B portfolio in Q3 2024.
  • Marshall Wace opened 616 new positions and closed 659 in Q3 2024.
  • Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $82.1B.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.